146 related articles for article (PubMed ID: 36476097)
1. Computational modelling of potential Zn-sensitive non-β-lactam inhibitors of imipenemase-1 (IMP-1).
Ayipo YO; Ahmad I; Alananzeh W; Lawal A; Patel H; Mordi MN
J Biomol Struct Dyn; 2023 Nov; 41(19):10096-10116. PubMed ID: 36476097
[TBL] [Abstract][Full Text] [Related]
2. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
[TBL] [Abstract][Full Text] [Related]
3. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
[TBL] [Abstract][Full Text] [Related]
5. Aspergillomarasmine A inhibits metallo-β-lactamases by selectively sequestering Zn
Sychantha D; Rotondo CM; Tehrani KHME; Martin NI; Wright GD
J Biol Chem; 2021 Aug; 297(2):100918. PubMed ID: 34181945
[TBL] [Abstract][Full Text] [Related]
6. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
7. H
Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
[TBL] [Abstract][Full Text] [Related]
8. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
[TBL] [Abstract][Full Text] [Related]
9. Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase.
Softley CA; Zak KM; Bostock MJ; Fino R; Zhou RX; Kolonko M; Mejdi-Nitiu R; Meyer H; Sattler M; Popowicz GM
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205343
[TBL] [Abstract][Full Text] [Related]
10. Potency of IMP-10 metallo-beta-lactamase in hydrolysing various antipseudomonal beta-lactams.
Zhao WH; Hu ZQ; Shimamura T
J Med Microbiol; 2008 Aug; 57(Pt 8):974-979. PubMed ID: 18628498
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the substrate specificity of IMP-6 and IMP-1 metallo-β-lactamases.
Yamamoto K; Tanaka H; Kurisu G; Nakano R; Yano H; Sakai H
J Biochem; 2022 Dec; 173(1):21-30. PubMed ID: 36174533
[TBL] [Abstract][Full Text] [Related]
12. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
13. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals.
Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS
Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421
[TBL] [Abstract][Full Text] [Related]
14. Non-β Lactam Inhibitors of the Serine β-Lactamase blaCTX-M15 in Drug-Resistant
Ahmad F; Parvaiz N; MacKerell AD; Azam SS
J Chem Inf Model; 2023 Nov; 63(21):6681-6695. PubMed ID: 37847018
[TBL] [Abstract][Full Text] [Related]
15. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
[TBL] [Abstract][Full Text] [Related]
16. New polyimidazole ligands against subclass B1 metallo-β-lactamases: Kinetic, microbiological, docking analysis.
Bognanni N; Brisdelli F; Piccirilli A; Basile L; La Piana L; Di Bella S; Principe L; Vecchio G; Perilli M
J Inorg Biochem; 2023 May; 242():112163. PubMed ID: 36842244
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
19. Difference in the Inhibitory Effect of Thiol Compounds and Demetallation Rates from the Zn(II) Active Site of Metallo-β-lactamases (IMP-1 and IMP-6) Associated with a Single Amino Acid Substitution.
Yamaguchi Y; Kato K; Ichimaru Y; Uenosono Y; Tawara S; Ito R; Matsuse N; Wachino JI; Toma-Fukai S; Jin W; Arakawa Y; Otsuka M; Fujita M; Fukuishi N; Sugiura K; Imai M; Kurosaki H
ACS Infect Dis; 2023 Jan; 9(1):65-78. PubMed ID: 36519431
[TBL] [Abstract][Full Text] [Related]
20. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios AR; Rossi MA; Mahler GS; Vila AJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
